focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 57.00
Bid: 56.00
Ask: 58.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.571%)
Open: 57.00
High: 57.00
Low: 57.00
Prev. Close: 57.00
MAV4 Live PriceLast checked at -
Maven Income and Growth VCT 4 is an Investment Trust

To achieve long term capital appreciation and generate income by investing the majority of its funds in a diversified portfolio of shares and securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restults of General Meeting and Class Meetings

26 Mar 2013 14:04

RNS Number : 9122A
Maven Income & Growth VCT 4 PLC
26 March 2013
 

Maven Income and Growth VCT 4 PLC

 

Results of Shareholder Meetings and Share Capital Consolidation

 

26 March 2013

 

This announcement is made by Maven Income and Growth VCT 4 PLC ("the Company") in connection with (i) the proposed consolidation of its share capital ("Share Consolidation") and (ii) the proposed merger of the Company with Ortus VCT PLC ("Ortus"), which will be completed pursuant to a scheme of reconstruction under Section 110 of the Insolvency Act 1986 whereby Ortus will transfer all of its assets and liabilities to the Company in consideration of shares being issued by the Company ("the Scheme"), details of which were contained in the Company's circular to shareholders ("Circular") and prospectus ("Prospectus") both dated 1 March 2013.

 

Results of the General Meeting and Class Meetings

 

The Board is pleased to announce that at the general meeting and class meetings of the Company held on 26 March 2013, the resolutions proposed in connection with the Share Consolidation and the Scheme and other matters, as set out in the Circular, were duly passed on a show of hands.

 

Details of the resolutions passed at the general meeting are as follows:

 

·; Resolution 1 to: (i) authorise the directors to allot shares pursuant to the share consolidation; (ii) redesignate each S ordinary share of 10p each ("S Shares") as an ordinary share of 10p each ("Ordinary Shares") and (iii) amend the articles of association of the Company to remove any reference to S Shares as a separate class of shares - 97.59% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 2 to: (i) approve the acquisition of all of the assets and liabilities of Ortus VCT PLC; (ii) amend the articles of association of the Company to provide for the rights attaching to, and the conversion of, C ordinary shares; (iii) authorise the directors to allot shares pursuant to the Scheme and (iv) authorise the buyback of deferred shares- 96.49% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 3 to approve a change to the investment policy as detailed in Part V of the Circular - 98.91% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 4 to: (i) authorise the directors to allot shares; (ii) disapply pre-emption rights and (iii) authorise the Company to make market purchases of shares - 98.74% of proxy votes received being in favour (or at the chairman's discretion);

·; Resolution 5 to: (i) authorise the cancellation of the amount standing to the credit of the share premium account as at the date an order is made the court and (ii) authorise the cancellation of the amount standing to the credit of the capital redemption reserve as at the date an order is made the court - 100% of proxy votes received being in favour (or at the chairman's discretion).

The resolutions passed at the Ordinary Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the Ordinary Shares resulting therefrom - 97.06% and 97.06% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

The resolutions passed at the S Share class meeting approved the passing of Resolution 1 and 2 at the general meeting and sanction any modification of the rights of the S Shares resulting therefrom - 81.80% and 81.80% of proxy votes received being in favour (or at the chairman's discretion), respectively.

 

A copy of the resolutions passed at the meetings will shortly be available for inspection on both the Company's website (www.mavencp.com) as well as at the National Storage Mechanism (www.morningstar.co.uk/uk/NSM).

 

 

Share Consolidation

 

Pursuant to the Share Consolidation, 804,028new S Shares have been issued today to the holders of S Shares on the Company's register on 25 March 2013 (this being the record date for the Share Consolidation). Application has been made to the UK Listing Authority for such shares to be admitted to the premium segment of the Official List, which is expected to take place on 27 March 2013.

 

Pursuant to Resolution 1 which was passed at the general meeting, immediately following the admission of such new S Shares to the Official List, all the S Shares then in issue in the capital of the Company will be redesignated as Ordinary Shares on a ratio of one to one. As a result, following completion of the Share Consolidation, holders of S Shares will hold 1.1528 Ordinary Shares for every S Share held on the record date for the Share Consolidation.

 

Applications will be made to the UK Listing Authority and London Stock Exchange in connection with the listing and admission of the new Ordinary Shares resulting from the Share Consolidation (and cancellation of the S Shares listing) which is expected to take effect on 28 March 2013. CREST accounts of shareholders who hold their Shares in CREST are expected to be updated and re-credited by 28 March 2013, with replacement share certificates dispatched to those who hold their share in certificated form expected to take place on 10 April 2013.

 

Following completion of the Share Consolidation, 15,225,880 Shares will be in issue. Therefore, the total number of voting rights in the Company will be 15,225,880, which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules.

 

For further enquiries please contact:

 

Maven Capital Partners UK LLP

0141 306 7400

enquries@mavencp.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDKAEDDEFF
Date   Source Headline
31st Aug 20213:27 pmRNSTransaction in Own Shares
27th Aug 20213:23 pmRNSHalf-year Report
24th Aug 20213:42 pmRNSTransaction in Own Shares
23rd Aug 20213:14 pmRNSTransaction in Own Shares
19th Aug 20213:04 pmRNSStatement re NAV and Interim Dividend
16th Jun 20213:16 pmRNSStatement re Offer for Subscription
24th May 20214:45 pmRNSTransaction in Own Shares
21st May 202111:02 amRNSIssue of Equity
17th May 20214:32 pmRNSStatement re Dividend Investment Scheme
12th May 20214:08 pmRNSNet Asset Value(s)
12th May 202112:37 pmRNSResult of AGM
9th Apr 20215:48 pmRNSAnnual Financial Report
24th Feb 20214:20 pmRNSTransaction in Own Shares
23rd Feb 20214:18 pmRNSTransaction in Own Shares
17th Feb 20214:37 pmRNSStatement re NAV and Final Dividend
8th Dec 20203:27 pmRNSTransaction in Own Shares
17th Nov 20204:26 pmRNSTransaction in Own Shares
16th Nov 20204:52 pmRNSTransaction in Own Shares
11th Nov 20205:01 pmRNSNet Asset Value(s)
2nd Oct 202012:41 pmRNSIssue of Equity
29th Sep 20204:49 pmRNSStatement re Dividend Investment Scheme
1st Sep 20204:35 pmRNSTransaction in Own Shares
28th Aug 20202:38 pmRNSHalf-year Report
26th Aug 20205:26 pmRNSTransaction in Own Shares
20th Aug 202011:38 amRNSStatement re NAV, Interim Dividend and DIS
20th Aug 202011:29 amRNSDirector Declaration
9th Jul 202010:00 amRNSIssue of Equity
8th Jun 20209:36 amRNSAllotment Update
21st May 202012:17 pmRNSResult of AGM
15th May 20204:10 pmRNSNet Asset Value(s)
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
21st Apr 20206:24 pmRNSAnnual Financial Report
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update and Suspension of DIS
20th Mar 20204:57 pmRNSTransaction in Own Shares
28th Feb 20204:56 pmRNSTransaction in Own Shares
24th Feb 20204:35 pmRNSStatement re Net Asset Value and Proposed Dividend
11th Feb 20205:04 pmRNSDirector/PDMR Shareholding
11th Feb 20205:02 pmRNSDirector/PDMR Shareholding
11th Feb 20204:24 pmRNSIssue of Equity
6th Feb 20203:39 pmRNSStatement re Offer for Subscription
18th Dec 20192:14 pmRNSDirectorate Change
18th Dec 20192:09 pmRNSMerger Update: Approval of Scheme
10th Dec 201912:30 pmRNSResult of General Meeting
14th Nov 20196:20 pmRNSStatement re Proposed Merger
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
7th Nov 20192:11 pmRNSNet Asset Value(s)
4th Oct 201911:30 amRNSDirector/PDMR Shareholding
4th Oct 201910:22 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.